Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis (Targeted Oncology, (2020), 15, 4, (495-501), 10.1007/s11523-020-00732-y)
- Iacovelli R.
- Ciccarese C.
- Facchini G.
- Milella M.
- Urbano F.
- Basso U.
- De Giorgi U.
- Sabbatini R.
- Santini D.
- Berardi R.
- Santoni M.
- Bracarda S.
- Massari F.
- Masini C.
- De Tursi M.
- Ricotta R.
- Buti S.
- Zustovich F.
- Sepe P.
- Rossetti S.
- Maruzzo M.
- Cortesi E.
- Tortora G.
- Procopio G.
Publication date
January 2020
DOI Publisher
Springer Science and Business Media LLCAbstract
While typesetting the article the Table 3 column/row entries are interchanged. Please find below the updated Table 3. (Table presented.)
Add to ORKG